Amgen (AMGN) Tops Q3 EPS by 60c, Offers Guidance
Tweet
Share
E-mail
Get Alerts AMGN Hot Sheet
Price: $439.33 +1.29%
Financial Fact:
Total operating expenses: 3.28B
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Total operating expenses: 3.28B
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Amgen (NASDAQ: AMGN) reported Q3 EPS of $5.64, $0.60 better than the analyst estimate of $5.04. Revenue for the quarter came in at $9.56 billion versus the consensus estimate of $8.98 billion.
GUIDANCE:
Amgen sees FY2025 EPS of $20.60-$21.40, versus the consensus of $21.04. Amgen sees FY2025 revenue of $35.8-36.6 billion, versus the consensus of $35.64 billion.
For earnings history and earnings-related data on Amgen (AMGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FTC files amicus brief challenging Amgen's Enbrel patent acquisition
- loanDepot receives NYSE non-compliance notice over stock price
- Amgen (AMGN) PT Raised to $400 at Cantor Fitzgerald on Higher Sales Estimates
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
